ZA200610273B - Compositions and methods for treatment of non-hodgkin's lymphoma - Google Patents
Compositions and methods for treatment of non-hodgkin's lymphoma Download PDFInfo
- Publication number
- ZA200610273B ZA200610273B ZA200610273A ZA200610273A ZA200610273B ZA 200610273 B ZA200610273 B ZA 200610273B ZA 200610273 A ZA200610273 A ZA 200610273A ZA 200610273 A ZA200610273 A ZA 200610273A ZA 200610273 B ZA200610273 B ZA 200610273B
- Authority
- ZA
- South Africa
- Prior art keywords
- unq733
- antibody
- pta
- polypeptide
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58513204P | 2004-07-02 | 2004-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200610273B true ZA200610273B (en) | 2008-06-25 |
Family
ID=35519991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200610273A ZA200610273B (en) | 2004-07-02 | 2005-06-30 | Compositions and methods for treatment of non-hodgkin's lymphoma |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7410772B2 (fr) |
| EP (1) | EP1802659A2 (fr) |
| JP (1) | JP2008505182A (fr) |
| KR (1) | KR20070036089A (fr) |
| CN (1) | CN101010342A (fr) |
| AU (1) | AU2005270078A1 (fr) |
| CA (1) | CA2568886A1 (fr) |
| RU (1) | RU2007104022A (fr) |
| WO (1) | WO2006014335A2 (fr) |
| ZA (1) | ZA200610273B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2176295B1 (fr) | 2007-07-16 | 2014-11-19 | Genentech, Inc. | Anticorps anti-cd79b humanisés, immunoconjugués, et procédés d'utilisation |
| PE20090943A1 (es) * | 2007-07-16 | 2009-08-05 | Genentech Inc | Anticuerpos anti-cd79b e inmunoconjugados |
| KR101607346B1 (ko) | 2008-01-31 | 2016-03-29 | 제넨테크, 인크. | 항-cd79b 항체 및 면역접합체 및 사용 방법 |
| EP2361263A1 (fr) * | 2008-10-31 | 2011-08-31 | Abbott Biotherapeutics Corp. | Utilisation d anticorps anti-cs1 pour le traitement des lymphomes rares |
| GB0920944D0 (en) | 2009-11-30 | 2010-01-13 | Biotest Ag | Agents for treating disease |
| WO2012098449A1 (fr) * | 2011-01-17 | 2012-07-26 | University Of Manitoba | Méthodes de traitement de troubles impliquant l'immunoglobuline a |
| US10260089B2 (en) | 2012-10-29 | 2019-04-16 | The Research Foundation Of The State University Of New York | Compositions and methods for recognition of RNA using triple helical peptide nucleic acids |
| HUE049175T2 (hu) | 2014-09-23 | 2020-09-28 | Hoffmann La Roche | Eljárás anti-CD79b immunkonjugátumok alkalmazására |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002008284A2 (fr) | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions et methodes diagnostiques et therapeutiques de troubles impliquant l'angiogenese |
| JP2002514058A (ja) | 1996-11-15 | 2002-05-14 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白およびそれらをコードするポリヌクレオチド |
| AU8173098A (en) | 1997-06-27 | 1999-01-19 | Ontogeny, Inc. | Neuroprotective methods and reagents |
| US6222029B1 (en) * | 1997-08-01 | 2001-04-24 | Genset | 5′ ESTs for secreted proteins expressed in brain |
| JP2002508167A (ja) | 1997-12-18 | 2002-03-19 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 110個のヒト分泌タンパク質 |
| US6579973B1 (en) | 1998-12-28 | 2003-06-17 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| EP1208195A2 (fr) | 1999-06-15 | 2002-05-29 | Genentech Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
| WO2001019988A1 (fr) | 1999-09-17 | 2001-03-22 | Genetics Institute, Inc. | Proteines secretees et polynucleotides codant pour ces proteines |
| AU6802801A (en) | 2000-03-01 | 2001-09-24 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU2001273150A1 (en) | 2000-07-20 | 2002-02-05 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU8678501A (en) | 2000-08-24 | 2002-03-04 | Genentech Inc | Compositions and methods for the diagnosis and treatment of tumor |
| US20060019256A1 (en) * | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| EP1664762A4 (fr) * | 2003-09-03 | 2008-08-13 | Us Gov Health & Human Serv | Procedes d'identification, de diagnostic et de prediction pour la survie des lymphomes |
-
2005
- 2005-06-30 KR KR1020067027830A patent/KR20070036089A/ko not_active Withdrawn
- 2005-06-30 WO PCT/US2005/023413 patent/WO2006014335A2/fr not_active Ceased
- 2005-06-30 EP EP05770980A patent/EP1802659A2/fr not_active Withdrawn
- 2005-06-30 JP JP2007520391A patent/JP2008505182A/ja not_active Withdrawn
- 2005-06-30 ZA ZA200610273A patent/ZA200610273B/en unknown
- 2005-06-30 CA CA002568886A patent/CA2568886A1/fr not_active Abandoned
- 2005-06-30 AU AU2005270078A patent/AU2005270078A1/en not_active Abandoned
- 2005-06-30 CN CNA2005800295488A patent/CN101010342A/zh active Pending
- 2005-06-30 RU RU2007104022/13A patent/RU2007104022A/ru unknown
- 2005-06-30 US US11/172,193 patent/US7410772B2/en not_active Expired - Fee Related
-
2007
- 2007-10-29 US US11/927,069 patent/US20080102468A1/en not_active Abandoned
-
2008
- 2008-06-13 US US12/139,220 patent/US20090054631A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070036089A (ko) | 2007-04-02 |
| RU2007104022A (ru) | 2008-08-10 |
| WO2006014335A2 (fr) | 2006-02-09 |
| CA2568886A1 (fr) | 2006-02-09 |
| US20090054631A1 (en) | 2009-02-26 |
| WO2006014335A3 (fr) | 2006-07-06 |
| CN101010342A (zh) | 2007-08-01 |
| US20080102468A1 (en) | 2008-05-01 |
| AU2005270078A1 (en) | 2006-02-09 |
| JP2008505182A (ja) | 2008-02-21 |
| US20060057148A1 (en) | 2006-03-16 |
| US7410772B2 (en) | 2008-08-12 |
| EP1802659A2 (fr) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2611778C (fr) | Preparations et methodes pour le diagnostic et le traitement d'une tumeur | |
| US8398982B2 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| US20090054631A1 (en) | Compositions and methods for treatment of non-hodgkin's lymphoma | |
| US20090142259A1 (en) | Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors | |
| US20050170368A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU2006235436A2 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| US20080193446A1 (en) | Compositions and Methods for the Diagnosis and Treatment of Tumor | |
| AU2008222926A1 (en) | Amelioration of cellular stress response | |
| MXPA06015122A (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKINâÇS LYMPHOMA |